Journal
ACS CHEMICAL BIOLOGY
Volume 13, Issue 1, Pages 11-25Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.7b00851
Keywords
-
Categories
Funding
- Australian Research Council [DP140100092]
- National Health and Medical Research Council [APP570844, APP1061761]
- Australian Commonwealth Government (Australian Postgraduate Award)
Ask authors/readers for more resources
Desferrioxamine B (DFOB) was discovered in the late 1950s as a hydroxamic acid metabolite of the soil bacterium Streptomyces pilosus. The exquisite affinity of DFOB for Fe(III) identified its potential for removing excess iron from patients with transfusion-dependent hemoglobin disorders. Many studies have used semisynthetic chemistry to produce DFOB adducts with new properties and broad ranging functions. More recent approaches in chemical biology have revealed some nuances of DFOB biosynthesis and discovered new DFOB-derived drugs and radiometal imaging agents. The current and potential applications of DFOB continue to inspire a rich body of chemical biology research focused on this bacterial metabolite.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available